Nasdaq
$2.67▲ 6.06%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $151.3MShares out 56.7M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
41- 1d agoAfter-hours26.10.24 06:158-KKey event#●●●
Medicus Pharma Ltd.Bullish
Medicus Pharma Ltd. received notice from Nasdaq on October 23, 2026, confirming that it has regained compliance with the minimum bid price requirement of $1.00 per share. Consequently, the previously received delisting determination has been superseded, and the matter is now considered closed.…more
$2.67+6.06%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 5d agoAfter-hours26.10.20 06:00PRE 14AOther
Medicus Pharma Ltd.
Medicus Pharma will hold a special meeting of shareholders on December 2, 2026, to vote on the authorization of new preferred shares and a reverse stock split of common shares at a ratio of up to 1:50. These proposals are intended to modify the company's capital structure, and shareholders are encouraged to cast their votes on these matters.…more
$2.67+6.06%vs prev closeView filingShare - 10.16After-hours26.10.17 06:21424B3Offering
Medicus Pharma Ltd.
Medicus Pharma Ltd. implemented a 1-for-50 share consolidation of its issued and outstanding common shares, effective October 12, 2026. As a result of this consolidation, every 50 common shares were combined into one new share, and proportionate adjustments were made to the exercise prices and quantities of all outstanding equity awards and warrants.…more
$2.67+6.06%vs prev closeView filingShare
40 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.8Pre-market26.10.08 21:00#●●●#●●●#●●●
Medicus Pharma Outlines Three-Year Progress and Strategic Roadmap
Medicus Pharma provided a three-year update highlighting its clinical pipeline progress and focus on capital-efficient drug development. The announcement outlines future strategic goals and partnership intentions rather than immediate financial results.…more
$2.67+6.06%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.8Overnight26.10.08 16:28
●●●●●●●● ●●●●● ●●●●●●
Medicus Pharma announced a 50-to-1 reverse stock split to regain compliance with Nasdaq's minimum bid price requirement. The move, which typically signals financial distress, led to a significant decline in the company's share price.…more
$2.67+6.06%vs prev closeShareBenzinga - 10.7After-hours26.10.08 05:09
●●●●●●●● ●●●●● ●●●●●●
Medicus Pharma has announced a 50-for-1 stock split scheduled to take effect on October 12. This corporate action is intended to increase liquidity by reducing the price per share.…more
$2.67+6.06%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report